Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
11,043,172
-
Share change
-
-917,167
-
Total reported value
-
$80,944,896
-
Put/Call ratio
-
97%
-
Price per share
-
$7.33
-
Number of holders
-
39
-
Value change
-
-$6,727,240
-
Number of buys
-
17
-
Number of sells
-
16
Institutional Holders of INTEC PHARMA LTD JERUSALEM - SHS as of Q1 2019
As of 31 Mar 2019,
INTEC PHARMA LTD JERUSALEM - SHS was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,043,172 shares.
The largest 10 holders included
MEITAV DASH INVESTMENTS LTD, Avoro Capital Advisors LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Sectoral Asset Management Inc, Migdal Insurance & Financial Holdings Ltd., Prosight Management, LP, DAFNA Capital Management LLC, ESSEX INVESTMENT MANAGEMENT CO LLC, Knott David M, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
39
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.